Cunningham’s letter outlines ways the university plans to “reject any and all forms of hatred directed toward members of our Jewish communities, regardless of their political beliefs.” ...

WICHITA, Kan. (KWCH) - The Wichita Area Metropolitan Planning Commission (WAMPO) presented its draft for a long-term transportation plan. The Metropolitan Transportation Plan 2050 will set the ...

Global Financehas announced selections for the World’s Best Financial Innovation Labs as part of The Innovators 2025. A full report on the results will be published in the June print and digital ...

Global Finance has named the Most Innovative Banks and Fintechs regionally and globally as part of the Innovators Awards for 2025. This is Global Finance’s twelfth annual awards program recognizing ...

Former U.S. Sen. David Perdue responds to questions from the Senate Foreign Relations Committee. Leaning into what he described as a bipartisan consensus on countering China’s sweeping global ...

The writer's Uncle Isaak & wife came to America at the turn of the century to escape the tyranny of Czar Alexander. Uncle Isaak went West, started a chemical plant and eventually became a wealthy ...

Both Democratic candidates for mayor in Gulfport see crime as the No. 1 issue in the city. Sonya Williams Barnes, a former member of the Mississippi House, said she would hope to reduce the crime ...

TURIN, Italy, March 27 (Reuters) - Newly-appointed Juventus manager Igor Tudor at his first press conference on Thursday emphasised the urgent need for swift tactical changes to rejuvenate the ...

NORFOLK, Neb. (KTIV) - The City of Norfolk has released its process and timeline for selecting its new police chief. “We’ve implemented a comprehensive selection process with broad-based input ...

Using photos from Raleigh’s past, Mayor Janet Cowell highlighted her plans for the future. ”Cities matter more than ever,” she said. “They are where we interface with the world. It’s ...

CEO Paula Ragan highlighted 2024 as a transformative year for X4 Pharmaceuticals, with the U.S. approval and launch of XOLREMDI (mavorixafor) for WHIM syndrome, a rare immunodeficiency condition ...